Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Next-Generation Sequencing in Medicine (Upcoming)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI2261

The binding of some human antiendothelial cell antibodies induces endothelial cell apoptosis.

A Bordron, M Dueymes, Y Levy, C Jamin, J P Leroy, J C Piette, Y Shoenfeld, and P Y Youinou

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Bordron, A. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Dueymes, M. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Levy, Y. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Jamin, C. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Leroy, J. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Piette, J. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Shoenfeld, Y. in: JCI | PubMed | Google Scholar

Laboratory of Immunology, "Institut de Synergie des Sciences et de la Santé," Brest University Medical School, F 29 609 Brest, France.

Find articles by Youinou, P. in: JCI | PubMed | Google Scholar

Published May 15, 1998 - More info

Published in Volume 101, Issue 10 on May 15, 1998
J Clin Invest. 1998;101(10):2029–2035. https://doi.org/10.1172/JCI2261.
© 1998 The American Society for Clinical Investigation
Published May 15, 1998 - Version history
View PDF
Abstract

The pathogenic role of antiendothelial cell antibodies (AECA) remains unclear. They are frequently associated with antibodies to anionic phospholipids (PL), such as phosphatidylserine (PS), which is difficult to reconcile with the distribution of PL molecular species within the plasma membrane. Since it is already known that PS is transferred to the outer face of the membrane as a preclude to apoptosis, the possibility exists that apoptosis is initiated by AECA. AECA-positive/anti-PL antibody-negative sera from eight patients with systemic sclerosis (SS) and 21 control patients were evaluated. Endothelial cells (EC) were incubated with AECA and the exposure of PS was established through the binding of annexin V. Hypoploid cell enumeration, DNA fragmentation, and optical and ultrastructural analyses of EC were used to confirm apoptosis. Incubation of EC with AECA derived from six of eight patients with SS led to the expression of PS on the surface of the cells. This phenomenon was significantly more frequent in SS (P < 0.04) than in control diseases. The redistribution of plasma membrane PS preceded other events associated with apoptosis: hypoploidy, DNA fragmentation, and morphology characteristic for apoptosis. Apoptosis-inducing AECA did not recognize the Fas receptor. We conclude that AECA may be pathogenic by inducing apoptosis.

Version history
  • Version 1 (May 15, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts